Ribosomal protein L21 pseudogene 48 (RPL21P48)

RPL21P48, also known as ribosomal protein L21 pseudogene 48, is a DNA sequence in the human genome classified as a processed pseudogene of the ribosomal protein L21 gene. While the parent gene encodes a structural component of the 60S ribosomal subunit in the cytoplasm involved in protein synthesis[1][3], the pseudogene does not code for a protein and lacks known biological or pathological functions. As with many ribosomal protein genes, multiple processed pseudogenes exist in the human genome, resulting from retrotransposition events during evolution[1][3][4]. There are no documented therapeutic, clinical, or functional roles for RPL21P48. Summary of status: RPL21P48 is not a functional gene or a drug target, but rather a genomic pseudogene. It should not be considered a therapeutic target, and there is nothing to suggest any direct biological or disease association for this locus. The core biological activity and disease relevance are restricted to the parent gene, Ribosomal protein L21 (RPL21), not its pseudogenes[1][3][4].

Other names

RPL21_17_503RPL21P48

None applicable.